198 related articles for article (PubMed ID: 26715565)
1. Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
Eisele YS; Duyckaerts C
Acta Neuropathol; 2016 Jan; 131(1):5-25. PubMed ID: 26715565
[TBL] [Abstract][Full Text] [Related]
2. Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain.
Bates K; Vink R; Martins R; Harvey A
Neurobiol Aging; 2014 Jun; 35(6):1345-51. PubMed ID: 24360504
[TBL] [Abstract][Full Text] [Related]
3. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
Savelieff MG; Lee S; Liu Y; Lim MH
ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
[TBL] [Abstract][Full Text] [Related]
4. Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex.
Welikovitch LA; Do Carmo S; Maglóczky Z; Szocsics P; Lőke J; Freund T; Cuello AC
Acta Neuropathol; 2018 Dec; 136(6):901-917. PubMed ID: 30362029
[TBL] [Abstract][Full Text] [Related]
5. Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease.
Oddo S; Caccamo A; Green KN; Liang K; Tran L; Chen Y; Leslie FM; LaFerla FM
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):3046-51. PubMed ID: 15705720
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
7. [Transmission of pathogenic protein aggregates in Alzheimer's disease].
Schwarzman AL; Sarantseva SV
Mol Biol (Mosk); 2017; 51(3):418-422. PubMed ID: 28707657
[TBL] [Abstract][Full Text] [Related]
8. Spreading of Pathology in Alzheimer's Disease.
Lv ZY; Tan CC; Yu JT; Tan L
Neurotox Res; 2017 Nov; 32(4):707-722. PubMed ID: 28623460
[TBL] [Abstract][Full Text] [Related]
9. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
10. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
12. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
13. Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein.
Maia LF; Kaeser SA; Reichwald J; Hruscha M; Martus P; Staufenbiel M; Jucker M
Sci Transl Med; 2013 Jul; 5(194):194re2. PubMed ID: 23863834
[TBL] [Abstract][Full Text] [Related]
14. The inside-out amyloid hypothesis and synapse pathology in Alzheimer's disease.
Gouras GK; Willén K; Faideau M
Neurodegener Dis; 2014; 13(2-3):142-6. PubMed ID: 24080821
[TBL] [Abstract][Full Text] [Related]
15. Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease.
Cho JE; Kim JR
Recent Pat CNS Drug Discov; 2011 Sep; 6(3):222-33. PubMed ID: 21834780
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-β and tau pathology of Alzheimer's disease induced by diabetes in a rabbit animal model.
Bitel CL; Kasinathan C; Kaswala RH; Klein WL; Frederikse PH
J Alzheimers Dis; 2012; 32(2):291-305. PubMed ID: 22785400
[TBL] [Abstract][Full Text] [Related]
17. Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes.
Fein JA; Sokolow S; Miller CA; Vinters HV; Yang F; Cole GM; Gylys KH
Am J Pathol; 2008 Jun; 172(6):1683-92. PubMed ID: 18467692
[TBL] [Abstract][Full Text] [Related]
18. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
[TBL] [Abstract][Full Text] [Related]
19. Regional distribution of tau, beta-amyloid and beta-amyloid precursor protein in the Alzheimer's brain: a quantitative immunolabelling study.
Shukla C; Bridges LR
Neuroreport; 1999 Dec; 10(18):3785-9. PubMed ID: 10716210
[TBL] [Abstract][Full Text] [Related]
20. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.
Vasconcelos B; Stancu IC; Buist A; Bird M; Wang P; Vanoosthuyse A; Van Kolen K; Verheyen A; Kienlen-Campard P; Octave JN; Baatsen P; Moechars D; Dewachter I
Acta Neuropathol; 2016 Apr; 131(4):549-69. PubMed ID: 26739002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
